Neuropsychoanalysis Group Mexico City

The Neuropsychoanalysis Group in Mexico City is happy to report the initiation of a research project by its three members, focusing on borderline pathology and the use of benzodiazepines. This study began in August of 2011 and has focused on the clinical problems addressed in the psychoanalytic treatment of this population, particularly the splitting of the transference. There is evidence that many patients do benefit from medication and that a psychoanalytic treatment can be held with the help of benzodiazepines. However, there is concern about the ease with which this sort of medication tends to be prescribed to the borderline population, due to the frequent referred symptom of vague anxiety. In addition, clinical case studies demonstrate that benzodiazepine can become an object to the patient, either of dependence or of rejection to dependence. Our findings so far suggest that the handling of a borderline patient medicated with benzodiazepines demands a neuropsychoanalytic understanding of the case and possibly of neuropsychoanalytic modifications to its technique.

The Universidad Intercontinental in Mexico City is also happy to announce the opening of a neuropsychoanalysis research department for its doctoral program in psychoanalysis, which began in January 2012. The objective is to facilitate the development of a neuropsychoanalytic understanding of clinical phenomena, supported by research conducted in collaboration with the National Institute of Neurology and Neurosurgery. The University began supporting Daniela Flores Mosri's neuropsychoanalytic research in 2010 and continues to be committed to contributing to a more interdisciplinary awareness of psychoanalysis in Mexico.

Daniela Flores Mosri presented a paper on adolescence and initial exposure to alcohol and cannabis, of great relevance to the particular vulnerability of Mexican adolescents to developing borderline organizations due to Mexico's current sociocultural context for the middle class. The discus